Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy

@article{Cooperberg2006MultiinstitutionalVO,
  title={Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy},
  author={Matthew R. Cooperberg and Stephen J. Freedland and David J. Pasta and Eric P. Elkin and Joseph Presti and Christopher L Amling and Martha K. Terris and William J Aronson and Christopher J. Kane and Peter R. Carroll},
  journal={Cancer},
  year={2006},
  volume={107}
}
The University of California, San Francisco (UCSF) Cancer of the Prostate Risk Assessment (CAPRA) is a novel preoperative index which predicts the risk of biochemical recurrence after radical prostatectomy. The performance of the index is at least as good as the best available instruments based on clinical variables, and the 0 to 10 score is simple to calculate for both clinical and research purposes. This study used a large external dataset to validate CAPRA. 

The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.

The new post-surgical CAPRA-S score performed better in both calibration and decision curve analyses, and offers good discriminatory accuracy, calibration, and ease of calculation for clinical and research settings.

External validation of the UCSF-CAPRA (University of California, San Francisco, Cancer of the Prostate Risk Assessment) in Japanese patients receiving radical prostatectomy.

The UCSF-CAPRA is an acceptable risk category tool comparable to that of the D'Amico risk classification for Japanese prostate cancer patients receiving radical prostatectomy in the contemporary Gleason grading era.

A Straightforward Tool for Improved Prediction of Outcomes After Radical Prostatectomy

The new postsurgical score (CAPRA-S) offers good discriminatory accuracy, calibration, and ease of calculation for clinical and research settings and performed better in both calibration and decision curve analyses.

External validation of the Briganti nomogram to estimate the probability of specimen‐confined disease in patients with high‐risk prostate cancer

An external validation of the updated nomogram from Briganti et’al.

External Validation of the Cancer of the Prostate Risk Assessment Score to Predict Biochemical Relapse after Radical Prostatectomy for Prostate Cancer in Japanese Patients

In Japanese patients, the CAPRA score can predict BCR after RP only to some degree, and its c-index is lower than the c-indices reported in other validation cohorts, which range from 0.68 to 0.81.

Prognostic value of the CAPRA clinical prediction rule: a systematic review and meta‐analysis

A systematic review examines the totality of evidence in relation to the predictive value of the CAPRA clinical predication rule by combining all studies that validate the rule.
...

References

SHOWING 1-10 OF 33 REFERENCES

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

A new preoperative nomogram provides robust predictions of prostate cancer recurrence up to 10 years after radical prostatectomy, and adds the prognostic information of systematic biopsy results, and enabled the predictions to be adjusted for the year of surgery.

Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.

Stratifying patients in CaPSURE into low, intermediate and high risk categories for disease as described by D'Amico or applying the Kattan nomogram resulted in statistically significant differences in predicted 5-year Freedom from progression (FFP).

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.

The UCSF-CAPRA score is a straightforward yet powerful preoperative risk assessment tool which would be a strong predictor of outcome across various levels of risk and which could be easily applied and intuitively understood.

Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).

Although concordance is lower than in previous validation studies and the nomogram overestimates recurrence-free survival in patients at lower risk, the model is fairly robust and it provides important information when counseling patients regarding treatment options in the community setting.

Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.

Patients at high risk for PCSM after PSA failure can be identified based on post-RP PSA-DT or post-RT P SA-DT and biopsy Gleason score, and these parameters may be useful in identifying patients for a randomized trial evaluating hormonal therapy with or without docetaxel.

Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma

In the current study, the authors sought to further stratify the prognosis of patients with Gleason score (GS) 7 prostate carcinoma by assessing the influence on outcome of a predominant poorly differentiated Gleason pattern and/or a coincident small focus of poorly differentiated tumor of higher grade.

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.

CaPSURE data confirm the usefulness of percent positive biopsies in risk assessment and they have further been used to validate multiple preoperative nomograms, and strongly affirm the necessity of patient reported quality of life assessment.

Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy.

The preoperative PSAV is a significant independent clinical factor predicting for relapse after RP and also predicts for larger, more aggressive, and more locally advanced tumors.

Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy.

The usefulness of preoperative PSA kinetics for predicting post-RRP outcomes is confirmed, which may be useful for stratifying patients, so that rational management decisions can be made with respect to observation, intervention and adjuvant treatment.